ACADIA Pharmaceuticals (ACAD)

Acadia Pharma Limited • Acadia Pharmaceuticals A/S • Acadia Pharmaceuticals GmbH • Acadia Pharmaceuticals Holdings Inc. • Acadia Pharmaceuticals (Canada) Inc. • Ontario, Canada • Acadia Pharmaceuticals (France) SAS • Acadia Pharmaceuticals (Germany) GmbH • Acadia Pharmaceuticals (Italy) S.R.L. • Acadia Pharmaceuticals (Netherlands) B.V. ...

IRS number

61376651

ACAD stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Latest filings (excl ownership)

View all

Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operating Overview

26 Feb 25

8-K

Completion of Acquisition or Disposition of Assets

11 Dec 24

8-K

Departure of Directors or Certain Officers

6 Nov 24

Acadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating Overview

6 Nov 24

S-8

Registration of securities for employees

23 Sep 24

8-K

Departure of Directors or Certain Officers

23 Sep 24

S-8 POS

Registration of securities for employees (post-effective amendment)

20 Aug 24

S-8 POS

Registration of securities for employees (post-effective amendment)

20 Aug 24

Transcripts

View all

ACAD

Earnings call transcript

2024 Q4

26 Feb 25

ACAD

Earnings call transcript

2024 Q3

6 Nov 24

ACAD

Earnings call transcript

2024 Q2

6 Aug 24

ACAD

Earnings call transcript

2024 Q1

8 May 24

ACAD

Earnings call transcript

2023 Q4

27 Feb 24

ACAD

Earnings call transcript

2023 Q3

2 Nov 23

ACAD

Earnings call transcript

2023 Q2

2 Aug 23

ACAD

Earnings call transcript

2023 Q2

2 Aug 23

ACAD

Earnings call transcript

2023 Q1

8 May 23

ACAD

Earnings call transcript

2022 Q4

27 Feb 23

Latest ownership filings

View all

ELIZABETH A. GAROFALO

6 Mar 25

144

Notice of proposed sale of securities

Financial summary

Financial statements Chart ACAD financial data

Quarter (USD)	Dec 24	Sep 24	Jun 24	Mar 24
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 24	Dec 23	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q4 2024

ACAD institutional ownership history Ownership history

97.4% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	294	257	+14.4%
Opened positions	71	37	+91.9%
Closed positions	34	44	-22.7%
Increased positions	108	88	+22.7%
Reduced positions	72	81	-11.1%

13F shares	Current	Prev Q	Change
Total value	2.89 tn	2.33 tn	+24.1%
Total shares	162.40 mm	154.32 mm	+5.2%
Total puts	350.10 k	314.00 k	+11.5%
Total calls	854.60 k	900.60 k	-5.1%
Total put/call ratio	0.4	0.3	+17.5%

Largest owners	Shares	Value	Change
Baker Bros. Advisors	42.88 mm	$786.81 bn	0.0%
Vanguard	13.95 mm	$255.94 bn	+0.8%
BlackRock	12.73 mm	$233.59 bn	-0.5%
RTW Investments	8.71 mm	$159.75 bn	-36.5%
MS Morgan Stanley	7.30 mm	$133.90 bn	+335.4%
STT State Street	4.52 mm	$82.97 bn	-24.3%
D. E. Shaw & Co.	3.24 mm	$59.48 bn	-7.5%
GS The Goldman Sachs Group, Inc.	2.88 mm	$52.86 bn	+63.8%
Geode Capital Management	2.88 mm	$52.81 bn	+0.1%
Palo Alto Investors	2.75 mm	$50.44 bn	+8.9%

Largest transactions	Shares	Bought/sold	Change
MS Morgan Stanley	7.30 mm	+5.62 mm	+335.4%
RTW Investments	8.71 mm	-5.00 mm	-36.5%
Point72 Asset Management	2.23 mm	+2.23 mm	NEW
SG Americas Securities	2.48 mm	+1.97 mm	+380.3%
C Citigroup	1.67 mm	+1.55 mm	+1288.3%
STT State Street	4.52 mm	-1.45 mm	-24.3%
Norges Bank	1.39 mm	+1.39 mm	NEW
GS The Goldman Sachs Group, Inc.	2.88 mm	+1.12 mm	+63.8%
Millennium Management	1.12 mm	-934.76 k	-45.5%
Finepoint Capital	0.00	-905.38 k	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

ACAD insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
5 Mar 25	Elizabeth A. Garofalo	Common Stock	Sell	Dispose S	No	No	18.23	4,919	89.67 k	17,595
24 Feb 25	Mark C. Schneyer	Common Stock	Sell	Dispose S	No	Yes	19.96	773	15.43 k	53,882
24 Feb 25	James Kihara	Common Stock	Sell	Dispose S	No	Yes	19.96	475	9.48 k	20,228
23 Feb 25	Mark C. Schneyer	Common Stock	Option exercise	Acquire M	No	No	0	1,353	0.00	54,655
23 Feb 25	Mark C. Schneyer	RSU Common Stock	Option exercise	Dispose M	No	No	0	1,353	0.00	0
23 Feb 25	James Kihara	Common Stock	Option exercise	Acquire M	No	No	0	840	0.00	20,703
23 Feb 25	James Kihara	RSU Common Stock	Option exercise	Dispose M	No	No	0	840	0.00	0
9 Dec 24	Thomas Garner	RSU Common Stock	Grant	Acquire A	No	No	0	45,372	0.00	45,372
9 Dec 24	Thomas Garner	Stock Option Common Stock	Grant	Acquire A	No	No	18.76	235,849	4.42 mm	235,849